Pancreatic islet β-cell replenishment can be driven by epithelial cells from exocrine pancreas via epithelial–mesenchymal transition (EMT) and the reverse process MET, while specified pancreatic mesenchymal cells control islet cell development and maintenance. The role of human islet-derived precursor cells (hIPCs) in regeneration and support of endocrine islets is under investigation. Here, we analyzed hIPCs as to their immunophenotype, multilineage differentiation capacity, and gene profiling, in comparison to human bone marrow-derived mesenchymal stem cells (hBM-MSCs). hIPCs and hBM-MSCs display a common mesenchymal character and express lineage-specific marker genes upon induction toward pancreatic endocrine and mesenchymal pathways of differentiation. hIPCs can go further along endocrine pathways while lacking some core mesenchymal differentiation attributes. Significance analysis of microarray (SAM) from 5 hBM-MSC and 3 hIPC donors mirrored such differences. Candidate gene cluster analysis disclosed differential expression of key lineage regulators, indicated a HoxA gene-associated positional memory in hIPCs and hBM-MSCs, and showed as well a clear transition state from mesenchyme to epithelium or vice versa in hIPCs. Our findings raise new research platforms to further clarify the potential of hIPCs to undergo complete MET thus contributing to islet cell replenishment, maintenance, and function.
Get full access to this article
View all access options for this article.
References
1.
KimSK, MacDonaldRJ. 2002. Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev, 12:540–547.
2.
Grapin-BottonA, MeltonDA. 2000. Endoderm development: from patterning to organogenesis. Trends Genet, 16:124–130.
3.
AttaliM, StetsyukV, BasmaciogullariA, AielloV, Zanta-BoussifMA, DuvillieB, ScharfmannR. 2007. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes, 56:1248–1258.
4.
DuvilliéB, AttaliM, BounacerA, RavassardP, BasmaciogullariA, ScharfmannR. 2006. The mesenchyme controls the timing of pancreatic beta-cell differentiation. Diabetes, 55:582–589.
BaraschJ. 2001. Genes and proteins involved in mesenchymal to epithelial transition. Curr Opin Nephrol Hypertens, 10:429–436.
10.
DavaniB, IkonomouL, RaakaBM, Geras-RaakaE, MortonRA, Marcus-SamuelsB, GershengornMC. 2007. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells, 27:27.
11.
ChaseLG, Ulloa-MontoyaF, KidderBL, VerfaillieCM. 2007. Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells. Diabetes, 56:3–7.
12.
WeinbergN, Ouziel-YahalomL, KnollerS, EfratS, DorY. 2007. Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic beta-cells. Diabetes, 56:1299–1304.
13.
GershengornMC, HardikarAA, WeiC, Geras-Raaka, B Marcus-SamuelsE, RaakaBM. 2004. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science, 306:2261–2264.
14.
RussHA, BarY, RavassardP, EfratS. 2008. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes, 57:1575–1583.
15.
EberhardtM, SalmonP, von MachMA, HengstlerJG, BrulportM, LinscheidP, SeboekD, OberholzerJ, BarberoA, MartinI, MullerB, TronoD, ZulewskiH. 2006. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun, 345:1167–1176.
16.
KarnieliO, Izhar-PratoY, BulvikS, EfratS. 2007. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells, 5:5.
17.
TangDQ, CaoLZ, BurkhardtBR, XiaCQ, LitherlandSA, AtkinsonMA, YangLJ. 2004. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes, 53:1721–1732.
18.
IqbalN. 2007. The burden of type 2 diabetes: strategies to prevent or delay onset. Vasc Health Risk Manag, 3:511–520.
19.
LimbertC, PathG, JakobF, SeufertJ. 2008. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus. Diabetes Res Clin Pract, 79:389–399.
20.
BrandhorstH, BrandhorstD, BrendelMD, HeringBJ, BretzelRG. 1998. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant, 7:489–495.
21.
RicordiC, LacyPE, FinkeEH, OlackBJ, ScharpDW. 1988. Automated method for isolation of human pancreatic islets. Diabetes, 37:413–420.
22.
ZulewskiH, AbrahamEJ, GerlachMJ, DanielPB, MoritzW, MüllerB, VallejoM, ThomasMK, HabenerJF. 2001. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 50:521–533.
23.
NöthU, OsyczkaAM, TuliR, HickokNJ, DanielsonKG, TuanRS. 2002. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res, 20:1060–1069.
24.
ZalzmanM, Anker-KitaiL, EfratS. 2005. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes, 54:2568–2575.
25.
TimperK, SeboekD, EberhardtM, LinscheidP, Christ-CrainM, KellerU, MüllerB, ZulewskiH. 2006. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun, 341:1135–1140.
26.
TusherVG, TibshiraniR, ChuG. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA, 98:5116–5121.
27.
BeissbarthT, SpeedTP. 2004. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics, 20:1464–1465.
28.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopDj, HorwitzE. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
29.
QuagginSE, SchwartzL, CuiS, IgarashiP, DeimlingJ, PostM, RossantJ. 1999. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development, 126:5771–5783.
JiangJ, AuM, LuK, EshpeterA, KorbuttG, FiskG, MajumdarAS. 2007. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells, 25:1940–1953.
40.
NicolasS, PapillonD, PerezY, CaubitX, Le ParcoY. 2003. The spatial restrictions of 5’HoxC genes expression are maintained in adult newt spinal cord. Biol Cell, 95:589–594.
41.
LianJB, JavedA, ZaidiSK, LengnerC, MontecinoM, van WijnenAJ, SteinJL, SteinGS. 2004. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr, 14:1–41.
42.
KarsentyG. 2008. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet, 9:183–196.
43.
BlankV. 2008. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?J Mol Biol, 376:913–925.
44.
DavaniB, ArielyS, IkonomouL, OronY, GershengornMC. 2008. Human islet-derived precursor cells can cycle between epithelial clusters and mesenchymal phenotypes. J Cell Mol Med[Epub ahead of print].
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
